Yang Song

Yang Song is an Associate Principal Scientist at AstraZeneca, where they manage next-generation sequencing practices and platforms for preclinical R&D. With a Ph.D. in Bioengineering from the University of California, Riverside, Yang has extensive experience in the biotechnology industry, including roles as a Senior Scientist and Scientist at Admera Health, and postdoctoral fellow at the Lieber Institute for Brain Development and the University of Pennsylvania. They have a strong expertise in bioassay development, molecular biology, and next-generation sequencing technologies.